Your browser does not support SVG.
  • HOME
  • PIPELINE
  • LEADERSHIP
  • DISEASES
    Acne vulgarisAtopic dermatitisHyperhidrosisPsoriasisVitiligo
  • NEWS
  • CAREERS
  • CONTACT

November 2018

November 2018

November 15, 2018

Dermavant Appoints Todd Zavodnick as Chief Executi ...

Read More

Recent Posts

  • Dermavant Sciences Announces Appointment of Dr. Philip M. Brown as Chief Medical Officer

  • Dermavant Sciences to Present New Data on Cerdulatinib for Atopic Dermatitis and Vitiligo at the 3rd Annual Inflammatory Skin Disease Summit

  • Dermavant Appoints Todd Zavodnick as Chief Executive Officer

  • Dermavant Sciences to Present Tapinarof Phase 2B Data on Patient-Reported Outcomes for Psoriasis and Atopic Dermatitis at the Fall Clinical Dermatology Conference

  • Dermavant Announces Changes to Leadership and Board of Directors

Archives

  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • April 2018
  • September 2017
  • July 2017
  • December 2016
  • November 2015

Categories

  • Dermavant Sciences
  • News
  • RVT-201
  • RVT-501
  • RVT-502
  • RVT-504
  • Tapinarof
  • Home
  • Pipeline
  • Leadership
  • Diseases
    Acne vulgarisAtopic dermatitisHyperhidrosisPsoriasisVitiligo
  • News
  • Careers
  • Contact

Copyright © 2018 Dermavant Sciences, Inc. All rights reserved.
Privacy Policy    |   Terms of Use